HPV Global Action webinar
HPV Global Action webinar HPV head and neck cancers: We need a control strategy now! Wednesday, 10th November 2021 18:00-19:00 CET Objectives: At the end of the presentation, the participants will be better informed about head and neck cancers: · their clinical burden · their natural clinical history · their early and late-stage signs and […]
IPVS webinar – HPV vaccine schedules and Sub-Saharan Africa
IPVS webinar – HPV vaccine schedules and Sub-Saharan Africa Monday, 24th January 2022 12:00-13:30 EST (New York) / 18:00-19:30 CET (Geneva) Topic: Sub Saharan Africa (SSA) has a very high burden of cervical cancer. HPV vaccines are being introduced in many countries in the region but there are many challenges in implementation for the adolescent […]
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses Wednesday, 23rd March 2022 12:00-13:00 EDT (New York) / 17:00-18:00 CET (Geneva) Topic: Have you missed the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses or would you like to learn more about HPV antiviral drugs? Join […]
IPVS webinar: Everything you need to know about HPV and pregnancy
IPVS webinar: Everything you need to know about HPV and pregnancy Thursday, 28th April 2022 12:00-13:30 EDT (New York) / 18:00-19:30 CEST (Geneva) Topic: Join our upcoming webinar to learn everything you need to know about HPV and pregnancy. HPV lesion treatment is known to be associated with obstetrical complications and now HPV infection in […]
Cervical cancer elimination in the Asia Pacific: Does one size fit all?
Register today for the IPVS regional webinar in collaboration with the Asia Pacific HPV Coalition: Cervical cancer elimination in the Asia Pacific: Does one size fit all? Saturday, 16 July 2022 08:00-09:00 CEST (Geneva)/ 14:00-15:00 SST (Singapore) Topic: During this session, the faculty will address the challenges in HPV vaccination, screening, and treatment in the […]
IPVS webinar – The Future of HPV research
IPVS webinar – The Future of HPV research, featuring IPVS early career recognition awardee 2023 Tuesday, May 16, 2023 8:00 – 9:00 PDT (Los Angeles) / 17:00 – 18:00 CEST (Geneva) Topic: Join this educational webinar to hear the IPVS early career recognition awardee share her exceptional research. This will be followed by a 35-minute […]
IPVS Regional Webinar 2021: Cervical Cancer Elimination in Asia Pacific
Register today for the IPVS regional webinar in collaboration with the APAC HPV Coalition: Session III: Cervical cancer vaccination & screening in the Asia pacific during the pandemic: Where do we go from here? 15 May 2021 08:00-9:00 CET (Geneva)/ 14:00-15:00 SST (Singapore) Topic: What are the main challenges in cervical cancer screening and prevention […]
IPVS webinar – Your patient is HPV+: what is next?
IPVS webinar – Your patient is HPV+: what is next? Tuesday, 13th July 2021 8:00 EDT (New York) / 14:00 CEST (Geneva) / 20:00 SST (Singapore) Topic: Given the strong evidence that HPV-based screening is more effective than cytology or naked visual inspection after application of acetic acid, more and more countries have switched or […]
Regional webinar: Cervical Cancer Elimination in the Asia Pacific – Time for Action
IPVS regional webinar in collaboration with the Asia Pacific HPV Coalition: Cervical Cancer Elimination in the Asia Pacific – Time for Action Friday, 25 August 2023 08:30-10:00 CEST (Geneva)/ 14:30-16:00 SGT (Singapore) Topic: Join us for a free webinar held jointly with the Asia Pacific HPV Coalition where we delve into the intricacies of implementing […]
IPVS webinar – HPV latency: more questions than answers
IPVS webinar – HPV latency: more questions than answers Wednesday, 29th September 2021 10:00 EDT (New York) / 16:00 CEST (Geneva) Topic: The ability of papillomaviruses to establish infection at human epithelial sites that is largely undetectable by most routine molecular diagnostic tests is indisputable. However, there remains considerable disagreement about what this ‘test negative, […]
